Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2015
03/05/2015WO2015031808A2 Diagnostic methods and compositions for treatment of glioblastoma
03/05/2015WO2015031787A2 Enhancing immunity to tuberculosis
03/05/2015WO2015031782A1 Combination therapy for the treatment of glioblastoma
03/05/2015WO2015031778A2 Compositions and methods for the treatment or prevention of tuberculosis
03/05/2015WO2015031698A1 Site-specific antibody conjugation methods and compositions
03/05/2015WO2015031667A2 Gitr antigen binding proteins
03/05/2015WO2015031541A1 Novel sez6 modulators and methods of use
03/05/2015WO2015031471A1 Serologic correlates of protection against bacillus anthracis infection
03/05/2015WO2015031385A1 Single molecule-overlapping read analysis for minor variant mutation detection in pathogen samples
03/05/2015WO2015031376A1 Scaffolds containing cytokines for tissue engineering
03/05/2015WO2015031119A1 Method for prophylaxis and/or treatment of erbb2 positive cancers
03/05/2015WO2015030613A1 Oral vaccine for fish
03/05/2015WO2015030539A1 An anti serum albumin fab-effector moiety fusion construct, and the preparing method thereof
03/05/2015WO2015029967A1 Antibody titer-increasing agent using lactic acid bacterium
03/05/2015WO2015029056A1 A bacterial vaccine and methods for manufacture thereof
03/05/2015WO2015029002A1 Modified gene from leishmania ssp., method for producing a protein and use as an antigen in a vaccine composition or in immunodiagnostics
03/05/2015WO2015028888A2 Pharmaceutical compositions to treat viral infection
03/05/2015WO2015028666A1 Neutralizing antibody or a fragment thereof specifically binding primate gm-csf for use in the treatment and/or prevention of psoriasis
03/05/2015WO2015028657A1 Antibodies neutralizing gm-csf for use in the treatment of rheumatoid arthritis or as analgesics
03/05/2015WO2015028575A1 Immunisation method by photochemical internalisation
03/05/2015WO2015028574A1 Compound and method for vaccination and immunisation
03/05/2015WO2015028546A1 Large scale production of viruses in cell culture
03/05/2015WO2015028541A1 Antigen delivery device and method
03/05/2015WO2015028478A1 Novel influenza antigens and antibodies
03/05/2015WO2015028455A1 Antibodies
03/05/2015WO2015028027A1 Anti-ADAM12 antibodies for the treatment of cancer
03/05/2015WO2015027915A1 In-vivo individualized system immunological therapeutic method and device
03/05/2015WO2015027906A1 Bifunctional fusion protein, preparation method therefor, and use thereof
03/05/2015WO2015027820A1 Use of human nectin-2 protein
03/05/2015WO2015027296A1 A method of treatment
03/05/2015US20150065781 Combination therapy for the treatment of glioblastoma
03/05/2015US20150064240 MUC1 Based Glycolipopeptide Vaccine with Adjuvant
03/05/2015US20150064236 Modified polynucleotides for the production of proteins
03/05/2015US20150064219 Methods and compositions for cancer immunotherapy using flagellin-tumor associated antigen fusion protein expressing tumor cells
03/05/2015US20150064218 Methods and materials for treating cancer
03/05/2015US20150064217 Pluripotent germ layer origin antigen presenting cancer vaccine
03/05/2015US20150064216 Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants
03/05/2015US20150064215 Therapeutic delivery and expression system, methods and uses thereof
03/05/2015US20150064214 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
03/05/2015US20150064212 Process for the preparation and use of a bivalent vaccine against morphine-heroin addiction
03/05/2015US20150064210 Humoral immune response against tumor antigens after treatment with a cancer antigen specific active immunotherapy and its association with improved clinical outcome
03/05/2015US20150064209 Methods for generating immunity to antigen
03/05/2015US20150064206 Compositions for treating uveitis
03/05/2015US20150064204 Gitr antigen binding proteins
03/05/2015US20150064200 Methods and compositions for 6-phosphogluconate dehydrogenase (6-pgd) as a target for lung cancer therapy
03/05/2015US20150064199 Cancer therapy using beta glucan and antibodies
03/05/2015US20150064198 Enhancing Immunity to Tuberculosis
03/05/2015US20150064194 Uses and Compositions for Treatment of Rheumatoid Arthritis
03/05/2015US20150064193 Methods of treating psoriatic arthritis (psa) using il-17 antagonists and psa response or non-response alleles
03/05/2015US20150064192 Mammalian cell surface antigens; related reagents
03/05/2015US20150064189 Method of Treating Cancer with DLL4 Antagonist and Chemotherapeutic Agent
03/05/2015US20150064183 Targeted therapeutic proteins
03/05/2015US20150064180 Combination therapy with cd4 lymphocyte depletion and mtor inhibitors
03/05/2015US20150064178 Diagnostic methods and compositions for treatment of glioblastoma
03/05/2015US20150064176 Methods for treating conditions associated with masp-2 dependent complement activation
03/05/2015US20150064173 Methods of treating a disease or disorder associated with bruton's tyrosine kinase
03/05/2015US20150064172 Methods of treating a disease or disorder associated with bruton's tyrosine kinase
03/05/2015US20150064171 Combinations of akt inhibitor compounds and chemotheraeptuc agents, and methods of use
03/05/2015US20150064132 Treatment Methods for Rheumatoid Arthritis
03/04/2015EP2843051A1 Anti-human cd69 antibody, and use thereof for medical purposes
03/04/2015EP2842968A1 Anti-IL-6 antibodies, compositions, methods and uses
03/04/2015EP2842967A1 Pegylated amyloid beta fab
03/04/2015EP2842964A1 Virtual method of determining a modified mRNA sequence
03/04/2015EP2842573A1 Monoclonal antibodies to Fibroblast Growth Factor receptor 2
03/04/2015EP2842572A1 Cell-derived viral vaccines with low levels of residual cell dna
03/04/2015EP2842571A1 Antibodies directed to GPNMB and uses thereof
03/04/2015EP2842570A1 Compositions and methods for the prevention and treatment of autoimmune conditions
03/04/2015EP2842569A1 One dose vaccination with Mycoplasma hyopneumoniae
03/04/2015EP2842568A1 Pharmaceutical composition for treating and/or preventing type i diabetes and application thereof
03/04/2015EP2842565A1 Antibody-mediated disruption of quorum sensing in bacteria
03/04/2015EP2841559A1 Glycoengineered outer membrane vesicles and use thereof as vaccines
03/04/2015EP2841558A1 Oncolytic clostridium ghonii strains, and methods of production and use
03/04/2015EP2841459A1 Anti-cd22 antibodies
03/04/2015EP2841458A1 Modified antibody regions and uses thereof
03/04/2015EP2841457A1 Anti-robo4-antibody
03/04/2015EP2841454A1 Anti-pdgf-c antibodies
03/04/2015EP2841453A1 Humanized and chimeric anti-factor c3 antibodies and uses thereof
03/04/2015EP2841452A1 Modified glycoproteins
03/04/2015EP2841103A1 Dr5 ligand drug conjugates
03/04/2015EP2841102A1 Methods and compositions for treating cancer
03/04/2015EP2841101A1 Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
03/04/2015EP2841100A1 Methods and compositions for treating and diagnosing acute myocardial infarction
03/04/2015EP2841099A1 Combination of cd37 antibodies with bendamustine
03/04/2015EP2841098A1 Nanoparticles for treatment of allergy
03/04/2015EP2841097A1 Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
03/04/2015EP2841096A2 Antigens and antigen combinations
03/04/2015EP2841095A1 Method of treatment of wrinkles using topical chemodenervating agents
03/04/2015EP2841094A1 Live attenuated salmonella enterica capm 6449 strain for oral vaccination of farm animal
03/04/2015EP2841093A2 Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
03/04/2015EP2841082A1 Protease-regulated antibodies
03/04/2015EP2841075A1 Agents and methods for treating and preventing seborrheic keratosis
03/03/2015US8969653 Extracellular vesicles derived from gram-positive bacteria, and use thereof
03/03/2015US8969542 HPV polyepitope constructs and uses thereof
03/03/2015US8969536 Torque teno virus (TTV) isolates and compositions
03/03/2015US8969533 Formulation of sugar solutions for continuous ultracentrifugation for virus purification
03/03/2015US8969530 Anti-clathrin heavy chain monoclonal antibody for inhibition of tumor angiogenesis and growth and application thereof
03/03/2015US8969529 Methods and compositions based on shiga toxin type 2 protein
03/03/2015US8969526 Antibody Fc variants
03/03/2015US8969520 Reagent for assaying anti-treponema pallidum antibody
03/03/2015US8969518 B7 family member zB7H6 and related compositions and methods
1 2 3 4 5 6 7 8 9 10 11 ... 1823